BIO-key International Shareholder Meeting Vote Results Pending

Ticker: BKYI · Form: 8-K · Filed: Aug 28, 2024 · CIK: 1019034

Bio Key International INC 8-K Filing Summary
FieldDetail
CompanyBio Key International INC (BKYI)
Form Type8-K
Filed DateAug 28, 2024
Risk Levellow
Pages2
Reading Time3 min
Sentimentneutral

Sentiment: neutral

Topics: shareholder-meeting, corporate-governance

Related Tickers: BKYI

TL;DR

BIO-key International held a shareholder meeting, but the vote results aren't out yet.

AI Summary

On August 22, 2024, BIO-key International, Inc. filed an 8-K report detailing a shareholder meeting where proposals were voted upon. The specific outcomes of these votes, including any approved resolutions or election results, were not disclosed in this filing.

Why It Matters

Shareholder votes are crucial for corporate governance, determining the direction of the company and the approval of significant proposals.

Risk Assessment

Risk Level: low — This filing is a procedural update regarding a shareholder meeting and does not contain new financial or operational risks.

Key Players & Entities

FAQ

What was the date of the shareholder meeting reported in this 8-K?

The earliest event reported in this 8-K was on August 22, 2024.

What is the company's full legal name and state of incorporation?

The company's full legal name is BIO-key International, Inc., and it is incorporated in Delaware.

What is the SEC file number for BIO-key International, Inc.?

The SEC file number for BIO-key International, Inc. is 001-13463.

What is the principal executive office address of BIO-key International, Inc.?

The principal executive office address is 101 Crawfords Corner Rd, Suite 4116, Holmdel, NJ 07733.

What is the purpose of this 8-K filing?

This 8-K filing is to report on the submission of matters to a vote of security holders.

Filing Stats: 727 words · 3 min read · ~2 pages · Grade level 10.9 · Accepted 2024-08-28 16:34:27

Filing Documents

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. BIO-key International, Inc. (the " Company ") held its Annual Meeting of Stockholders (the " Annual Meeting ") on Thursday August 22, 2024. All holders of record of the Company's common stock outstanding as of the close of business on July 1, 2024 were entitled to vote at the Annual Meeting. At the Annual Meeting, stockholders approved the proposals set forth below. Each of the proposals is more fully described in the Company's definitive proxy statement, which was filed with the Securities and Exchange Commission on July 10, 2024. 1. Proposal to elect the following nominees to serve as members of the Company's board of directors for a one-year term: Michael W. DePasquale, Wong Kwok Fong (Kelvin), Robert J. Michel, Emmanuel Alia, and Cameron E. Williams. Each of the nominees were elected and the final voting results were as follows: Name Votes For Withheld Broker Non-Votes Michael DePasquale 368,965 98,549 667,346 Wong Kwok Fong (Kelvin) 368,940 98,574 667,346 Robert J. Michel 368,741 98,773 667,346 Emmanuel Alia 349,187 118,327 667,346 Cameron E. Williams 368,582 98,932 667,346 2. Proposal to ratify the selection of Bush & Associates CPA LLC as the Company's independent registered public accounting firm for the year ending December 31, 2024. The proposal was approved, and the final voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes 831,104 112,537 191,219 0 3. Proposal to approve, on a non-binding and advisory basis, the compensation paid to the Company's named executive officers. The proposal was approved, and the final voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes 302,123 101,061 64,330 667,346 4. Proposal to approve, on a non-binding and advisory basis, the frequency of the advisory approval of the compensation paid to the Company's named executive officers. Submitting th

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIO-KEY INTERNATIONAL, INC. Date: August 28, 2024 By: /s/ Cecilia C. Welch Cecilia C. Welch Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing